Search Results - "TRIOZZI, P. L"

Refine Results
  1. 1

    Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands by ALDRICH, W. A, REN, C, WHITE, A. F, ZHOU, S.-Z, KUMAR, S, JENKINS, C. B, SHAW, D. R, STRONG, T. V, TRIOZZI, P. L, PONNAZHAGAN, S

    Published in Gene therapy (01-01-2006)
    “…The potential of adeno-associated virus (AAV)-based vectors in human gene therapy is being explored for several diseases. Although sustained transgene…”
    Get full text
    Journal Article
  2. 2

    Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells by PEREBOEV, A. V, ASIEDU, C. K, DMITRIEV, I. P, KAWAKAMI, Y, DONG, S. S, BLACKWELL, J. L, KASHENTSEVA, E. A, TRIOZZI, P. L, ALDRICH, W. A, CURIEL, D. T, THOMAS, J. M

    Published in Gene therapy (01-09-2002)
    “…A promising approach to immunotherapy involves the loading of dendritic cells (DCs) with genetic material to facilitate sustained expression of a relevant…”
    Get full text
    Journal Article
  3. 3

    Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine by DAKAPPAGARI, N. K, DOUGLAS, D. B, TRIOZZI, P. L, STEVENS, V. C, KAUMAYA, P. T. P

    Published in Cancer research (Chicago, Ill.) (15-07-2000)
    “…Synthetic peptide vaccines targeting B-cell epitopes of the extracellular domain of the HER-2 oncoprotein were evaluated for their capacity to elicit…”
    Get full text
    Journal Article
  4. 4

    Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists by Triozzi, P L, Aldrich, W, Ponnazhagan, S

    Published in Cancer gene therapy (01-12-2011)
    “…Carcinoembryonic antigen (CEA) is a cancer vaccines’ target. Several features of recombinant adeno-associated virus (rAAV) are attractive for vaccine…”
    Get full text
    Journal Article
  5. 5

    B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity by PAUL, D. B, BARTH, R. F, YANG, W, SHEN, G.-H, KIM, J, TRIOZZI, P. L

    Published in Gene therapy (01-06-2000)
    “…Enhanced immunogenicity has been reported following transfection of a variety of immunogenic tumors with the B7.1 co-stimulatory molecule. The purpose of the…”
    Get full text
    Journal Article
  6. 6

    Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer by TRIOZZI, P. L, STEVENS, V. C, ALDRICH, W, POWELL, J, TODD, C. W, NEWMAN, M. J

    Published in Clinical cancer research (01-12-1997)
    “…The clinical and immunological effects of a vaccine consisting of CTP37, a synthetic peptide corresponding to the COOH-terminal peptide (CTP) of beta-human…”
    Get full text
    Journal Article
  7. 7

    Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages by Triozzi, Pierre L., Aldrich, Wayne

    Published in Journal of leukocyte biology (01-05-1997)
    “…We compared dendritic cells (DC) derived from CD34+ hematopoietic progenitor cells with tumor necrosis factor α and granulocyte‐macrophage colony‐stimulating…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor by Triozzi, P L, Tucker, F, Benzies, T, Balcerzak, S P

    Published in Bone marrow transplantation (Basingstoke) (01-07-1996)
    “…The characteristics of PBSC mobilized with GM-CSF, which has been shown to augment monocyte/macrophage (Mo/Mx) antitumor and accessory activities, were…”
    Get more information
    Journal Article
  10. 10

    HIV type 1-reactive chemokine-producing CD8+ and CD4+ cells expanded from infected lymph nodes by Triozzi, P L, Bresler, H S, Aldrich, W A

    Published in AIDS research and human retroviruses (20-05-1998)
    “…The chemokines RANTES, MIP-1alpha, and MIP-1beta have been identified as HIV-1-suppressive factors produced by CD8+ T cells. We examined the possibility that…”
    Get more information
    Journal Article
  11. 11

    Genetically Targeted Adenovirus Vector Directed to CD40-Expressing Cells by Belousova, Natalya, Korokhov, Nikolay, Krendelshchikova, Valentina, Simonenko, Vera, Mikheeva, Galina, Triozzi, Pierre L, Aldrich, Wayne A, Banerjee, Papia T, Gillies, Stephen D, Curiel, David T, Krasnykh, Victor

    Published in Journal of Virology (01-11-2003)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12

    Modulation of CD4 cell cytokine production by colon cancer-associated mucin by KIM, J. A, DAYTON, M. A, ALDRICH, W, TRIOZZI, P. L

    Published in Cancer Immunology, Immunotherapy (01-12-1999)
    “…Mucins have been implicated in tumor-associated immunosuppression. The possibility that colon cancer mucin (CCM) may modulate T-helper 1 (TH1) activity was…”
    Get full text
    Journal Article
  13. 13

    Phase I trial of escalating doses of interleukin-1 beta in combination with a fixed dose of interleukin-2 by Triozzi, P L, Kim, J A, Martin, E W, Young, D C, Benzies, T, Villasmil, P M

    Published in Journal of clinical oncology (01-02-1995)
    “…Interleukin-1 (IL-1) and IL-2 have synergistic antitumor and myelostimulatory activities. We investigated the clinical and biologic effects of IL-1/IL-2…”
    Get more information
    Journal Article
  14. 14

    Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer by Triozzi, Pierre L., Khurram, Reema, Aldrich, Wayne A., Walker, Michael J., Kim, Julian A., Jaynes, Sean

    Published in Cancer (15-12-2000)
    “…BACKGROUND Dendritic cells (DCs) are potent initiators of immune responses, and the infiltration of DCs into tumors may confer an improved prognosis. Whether…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Cellular Immunotherapy of Advanced Human Immunodeficiency Virus Type 1 Infection Using Autologous Lymph Node Lymphocytes: Effects on Chemokine Production by Triozzi, Pierre L., Aldrich, Wayne, Bresler, Herbert S., Para, Michael F., Flancbaum, Louis J.

    Published in The Journal of infectious diseases (01-01-1999)
    “…A pilot study was undertaken in patients with human immunodeficiency virus type 1 (HIV-1) infection to examine the effects of infusing autologous lymph node…”
    Get full text
    Journal Article
  18. 18

    Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma by Triozzi, P L, Walker, M J, Pellegrini, A E, Dayton, M A

    Published in Cancer investigation (1996)
    “…Twenty-five patients with metastatic malignant melanoma were treated with isotretinoin (13-cis-retinoic acid) orally at 1 mg/kg daily and recombinant…”
    Get more information
    Journal Article
  19. 19

    Optimum management of nausea and vomiting in cancer chemotherapy by TRIOZZI, P. L, LASZLO, J

    Published in Drugs (New York, N.Y.) (01-07-1987)
    “…Nausea and vomiting continue to be critical problems in cancer chemotherapy, although considerable progress has been made toward understanding the…”
    Get full text
    Journal Article
  20. 20

    Identification and activation of tumor-reactive cells for adoptive immunotherapy by Triozzi, P L

    Published in Stem cells (Dayton, Ohio) (01-05-1993)
    “…The use of adoptive immunotherapy to treat cancer has several potential advantages. Although extensive evaluation has been undertaken, issues regarding the…”
    Get more information
    Journal Article